Cencora, Inc. (COR) vs Regeneron Pharmaceuticals, Inc. (REGN)
A side-by-side comparison of Cencora, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.
COR
Cencora, Inc.
$321.57HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
REGN
Regeneron Pharmaceuticals, Inc.
$781.49HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — COR vs REGN
growth of $100 · dividends reinvested · last 10yCOR +351.5% (+16.3%/yr)REGN +108.5% (+7.6%/yr)COR compounded faster over this window
COR REGN
COR vs REGN: by the numbers
- •REGN is the larger company ($80.51B vs $62.57B market cap).
- •REGN trades at the lower trailing earnings multiple (19.33 vs 23.89 P/E), one valuation lens rather than an overall verdict.
- •REGN converts more revenue to profit (27.86% vs 0.79% net margin).
- •COR grew revenue faster over the past five years (10.25% vs 4.64% CAGR).
- •COR pays the higher dividend yield (0.75% vs 0.46%).
Metrics side by side
Valuation
| Metric | COR | REGN |
|---|---|---|
| P/E ratio | 23.89 | 19.33 |
| Forward P/E | 17.99 | 14.40 |
| P/S ratio | 0.19 | 5.18 |
| P/B ratio | 20.51 | 2.54 |
| EV / EBITDA | 13.27 | 17.79 |
| FCF yield | 6.49% | 4.37% |
Profitability
| Metric | COR | REGN |
|---|---|---|
| Gross margin | 3.71% | 84.86% |
| Operating margin | 1.30% | 25.56% |
| Net margin | 0.79% | 27.86% |
| ROE | 86.03% | 13.65% |
| ROIC | 12.75% | 9.19% |
Dividends
| Metric | COR | REGN |
|---|---|---|
| Dividend yield | 0.75% | 0.46% |
| Payout ratio | 17.83% | 9.15% |
Growth (annualized)
| Metric | COR | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 10.25% | 4.64% |
| EPS CAGR (5Y) | 11.97% | 5.70% |
| FCF CAGR (5Y) | 9.63% | 15.77% |
| Total return CAGR (5Y) | 22.92% | 4.76% |
Frequently asked
- Which has the lower trailing P/E, COR or REGN?
- REGN has the lower trailing P/E: COR trades at 23.89 and REGN at 19.33. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, COR or REGN?
- Over the past five years, COR grew revenue faster — COR at a 10.25% CAGR versus REGN at 4.64%.
- Does COR or REGN pay a bigger dividend?
- COR yields 0.75% and REGN yields 0.46% based on trailing dividends and the latest price.
- Is COR or REGN more profitable?
- REGN runs the higher net margin — COR at 0.79% versus REGN at 27.86%.
- How have COR and REGN total returns compared?
- Over the past 10 years, COR delivered 16.40% and REGN delivered 7.81% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cencora P/E ratioRegeneron Pharmaceuticals P/E ratioCencora dividend yieldRegeneron Pharmaceuticals dividend yieldCencora ROERegeneron Pharmaceuticals ROECencora operating marginRegeneron Pharmaceuticals operating marginCencora revenue growthRegeneron Pharmaceuticals revenue growthCencora free cash flowRegeneron Pharmaceuticals free cash flow
Cencora & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.